Cargando…

The Efficacy of Bethesda System for Prediction of Thyroid Malignancies- A 9 Year Experience from a Tertiary Center

INTRODUCTION: The best initial investigation for thyroid nodule is fine needle aspiration (FNA). Bethesda System is an international standardized system of reporting thyroid nodules and recommends subsequent management. Every institution should assess the risk of malignancy in each category to avoid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pasha, Hamdan Ahmed, Mughal, Ainulakbar, Wasif, Muhammad, Dhanani, Rahim, Haider, Syed Arish, Abbas, Sayed Akbar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mashhad University of Medical Sciences 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339890/ https://www.ncbi.nlm.nih.gov/pubmed/34395320 http://dx.doi.org/10.22038/ijorl.2021.50538.2687

Ejemplares similares

Malignancy Rate in Thyroid Nodules with Atypia or Follicular Lesion of Undetermined Significance
por: Pasha, Hamdan Ahmed, et al.
Publicado: (2020)

Are Bethesda III Thyroid Nodules More Aggressive than Bethesda IV Thyroid Nodules When Found to Be Malignant?
por: Turkdogan, Sena, et al.
Publicado: (2020)

Malignancy Rates in Thyroid Nodules Classified as Bethesda Categories III and IV: Retrospective Data from a Tertiary Center
por: Godoi Cavalheiro, Beatriz, et al.
Publicado: (2017)

Incidence and malignancy rates classified by The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) – An 8-year tertiary center experience in Thailand
por: Thewjitcharoen, Yotsapon, et al.
Publicado: (2018)

Malignancy rates in thyroid nodules classified as Bethesda categories III and IV; a subcontinent perspective
por: Zahid, Adnan, et al.
Publicado: (2021)

The Utility of Frozen Sections in the Evaluation of Clear Margins in Oral Squamous Cell Carcinomas: A Cross-Sectional Study From a Tertiary Care Center
por: Wasif, Muhammad, et al.
Publicado: (2022)

Reproducibility of Cytomorphological Diagnosis and Assessment of Risk of Malignancy of Thyroid Nodules Based on the Bethesda System for Reporting Thyroid Cytopathology: A Tertiary Cancer Center Perspective
por: Panda, Sasmita, et al.
Publicado: (2022)

Predictors of Malignancy in Thyroid Nodules Classified as Bethesda Category III
por: Liu, Xiaoli, et al.
Publicado: (2022)

Evaluation of thyroid nodules classified as Bethesda category III on cytology and their malignancy rate: An institutional experience
por: Almahari, Sayed Ali, et al.
Publicado: (2019)

Impact of Ultrasonographic Features for Thyroid Malignancy in Patients With Bethesda Categories III, IV, and V: A Retrospective Observational Study in a Tertiary Center
por: Hacim, Nadir Adnan, et al.
Publicado: (2021)

Ethical Dilemmas in the Management of Head and Neck Cancers in the Era of the COVID-19 Pandemic
por: Dhanani, Rahim, et al.
Publicado: (2022)

Malignancy risk in Bethesda class IV thyroid nodules in an iodine deficient region
por: Loderer, Tommaso, et al.
Publicado: (2023)

Association of thiol/disulphide homeostasis with Bethesda classification of thyroid nodules and thyroid cancer
por: BİLGİNER, Muhammet Cüneyt, et al.
Publicado: (2022)

Bethesda System for Reporting Thyroid Cytopathology: A three-year study at a tertiary care referral center in Saudi Arabia
por: Al Dawish, Mohamed Abdulaziz, et al.
Publicado: (2017)

Malignancy rates for Bethesda III subcategories in thyroid fine needle aspiration biopsy (FNAB)
por: Mosca, Leticia, et al.
Publicado: (2018)

Hashimoto’s Thyroiditis Does Not Influence the Malignancy Risk in Nodules of Category III in the Bethesda System
por: Słowińska-Klencka, Dorota, et al.
Publicado: (2022)

Malignancy in Thyroid Nodules with Bethesda III Category on Repeat Fine Needle Aspiration Biopsy*
por: Lourdes Ng, Jennifer, et al.
Publicado: (2023)

Low reproducibility of equivocal categories of the Bethesda System for Reporting Thyroid Cytology makes the associated risk of malignancy specific to the diagnostic center
por: Słowińska-Klencka, Dorota, et al.
Publicado: (2021)

Malignancy Rate of Bethesda Class III Thyroid Nodules Based on the Presence of Chronic Lymphocytic Thyroiditis in Surgical Patients
por: Cho, Yoon Young, et al.
Publicado: (2021)

Incidence and Malignancy Rates of Diagnoses in the Bethesda System for Reporting Thyroid Aspiration Cytology: An Institutional Experience
por: Park, Ji Hye, et al.
Publicado: (2014)

Surgical Outcome and Malignant Risk Factors in Patients With Thyroid Nodule Classified as Bethesda Category III
por: Huang, Jianhao, et al.
Publicado: (2021)

AI diagnosis of Bethesda category IV thyroid nodules
por: Yao, Jincao, et al.
Publicado: (2023)

Correlation between Ultrasound-based TIRADS and Bethesda System for Reporting Thyroid-cytopathology: 2-year Experience at a Tertiary Care Center in India
por: Periakaruppan, Gokulakrishnan, et al.
Publicado: (2018)

CSI: Bethesda
por: Shaw, Philip
Publicado: (2006)

Leaving Bethesda
por: Kim, Tae-Il
Publicado: (2016)

Evaluation of thyroid nodules classified as Bethesda category III on FNAC
por: Garg, Shiwani, et al.
Publicado: (2017)

Thyroid Nodules Cytopathology Applying the Bethesda System with Histopathological Correlation
por: Zarif, Hawazen A., et al.
Publicado: (2018)

The Bethesda System for Reporting Thyroid Cytopathology: A Cytohistological Study
por: Anand, Bakiarathana, et al.
Publicado: (2020)

Radiofrequency ablation for thyroid Bethesda III nodules: preliminary results
por: Chiang, Pi-Ling, et al.
Publicado: (2023)

Managing Bethesda IV thyroid nodules in an iodine-deficient population
por: Badash, Ido, et al.
Publicado: (2023)

A study of malignancy rates in different diagnostic categories of the Bethesda system for reporting thyroid cytopathology: An institutional experience
por: Arul, P., et al.
Publicado: (2015)

Malignancy rate of Bethesda category III thyroid nodules according to ultrasound risk stratification system and cytological subtype
por: Yoo, Won Sang, et al.
Publicado: (2020)

Association of patient characteristics, ultrasound features, and molecular testing with malignancy risk in Bethesda III–V thyroid nodules
por: Talmor, Guy, et al.
Publicado: (2022)

Correlation between Thyroid Imaging Reporting and Data System and Bethesda System of Reporting of Thyroid Cytopathology of Thyroid Nodule: A Single Center Experience
por: Biswas, Ananya, et al.
Publicado: (2020)

Ultrasound characteristics of thyroid nodules facilitate interpretation of the malignant risk of Bethesda system III/IV thyroid nodules and inform therapeutic schedule
por: Li, Fu, et al.
Publicado: (2019)

The Diagnostic Performance of Thyroid US in Each Category of the Bethesda System for Reporting Thyroid Cytopathology
por: Park, So Yoon, et al.
Publicado: (2016)

Cytological diagnosis of pediatric thyroid nodule in perspective of the Bethesda System for Reporting Thyroid Cytopathology
por: Pantola, Chayanika, et al.
Publicado: (2016)

The impact of thyroid imaging reporting and data system on the management of Bethesda III thyroid nodules()
por: Alqahtani, Saad M., et al.
Publicado: (2022)

Diagnostic accuracy of Bethesda system for reporting thyroid cytopathology: an institutional perspective
por: Naz, Samreen, et al.
Publicado: (2014)

Reproducibility of the Bethesda System for Reporting Thyroid Cytopathology: A Methodological Issue
por: Naderi, Mehdi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mq4gn7kv7n2j5ktilaj6trrvr8